Role of Mycobacterium tuberculosis protease in pathogenesis and host response
结核分枝杆菌蛋白酶在发病机制和宿主反应中的作用
基本信息
- 批准号:7319922
- 负责人:
- 金额:$ 1.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAntibody FormationApoptosisAttenuatedB-LymphocytesBacteriaBiochemicalBiologicalBiological AssayBiological ProcessCalmette-Guerin BacillusCellsCellular StructuresCessation of lifeCleaved cellCollaborationsComplementDataDatabasesDoctor of PhilosophyEndopeptidasesEnvironmentEpitopesFutureGenesGenomeGenus MycobacteriumGoalsGrowthHumanImmuneImmune responseImmunityImmunologicsIn VitroInfectionIntegration Host FactorsLife StyleLipoproteinsLocalizedLungMediatingModelingMolecularMusMutateMycobacterium tuberculosisNatureNecrosisNitric OxidePathogenesisPathologyPeptide HydrolasesPeptide Signal SequencesPhenotypePhysiologicalPlayPopulationPredispositionPrincipal InvestigatorProcessProteinsProteolytic ProcessingRecombinantsResearch PersonnelRestRoleSerineSignal TransductionSiteSpecificitySpleenStructureSurfaceT-LymphocyteTestingTherapeutic InterventionTimeTissuesTuberculosisVaccinesViralVirulence Factorsattenuationbacterial geneticsbasecell envelopechemokinecytokinedesignextracellularin vivoinsightintracellular protein transportkillingslymph nodesmacrophagemicrobicidemutantpathogenprogramsprotein localization locationprotein protein interactionresponsesuccesstoolvaccine developmentyeast proteinyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): Mycobacterium tuberculosis is a highly successful human pathogen that has evolved to survive within the host. Our long-term goals are to delineate the mechanisms by which M. tuberculosis interferes with the microbicidal functions of macrophages and evades host immune responses. Understanding the molecular mechanisms underlying M. tuberculosis- host interactions is important for designing therapeutic interventions and vaccine strategies. We have identified Rv2224c, a predicted protease, as being critical for survival in macrophages and in vivo. We hypothesize that Rv2224c is an important virulence factor that proteolytically cleaves M. tuberculosis substrates and modulates the host immune response. Our preliminary studies indicate that Rv2224c is exported to the cell envelope of mycobacteria and secreted extracellularly. A mutant disrupted in the protease is impaired for growth in macrophages and in vivo. Mice infected with a protease mutant show markedly reduced lung pathology and survive longer than wild type-infected mice. In this proposal will study the role of the protease in host-pathogen interactions. The specific aims are: 1. Molecular and biochemical characterization of Rv2224c and its potential substrate(s) in M. tuberculosis. We will study the localization of Rv2224c in mycobacteria and perform structure-function analysis of Rv2224c. We will investigate the biological activity and specificity of the protease by studying a candidate physiologic substrate. 2. Study the interaction of the protease with the host immune response in macrophages and in vivo. We will examine the nature of the immune response to Rv2224c mutant, specifically determine the role of T and B cells in immunity and perform structure-function analysis of protease interaction with the host in macrophages and in vivo. 3. Dissect the modulation of macrophage function by the protease. We will ask whether infection with the mutant elicits altered macrophage responses and test whether the Rv2224c::tn mutant is hyper-susceptible to IFNy-mediated immune responses. Finally, we will study whether Rv2224 directly interacts with host cell components using protein-protein
interaction studies.
描述(由申请人提供):结核分枝杆菌是一种非常成功的人类病原体,已进化为在宿主体内生存。我们的长期目标是阐明M。结核病干扰巨噬细胞的杀微生物功能并逃避宿主免疫应答。了解M.结核病与宿主的相互作用对设计治疗干预措施和疫苗战略很重要。我们已经鉴定了Rv 2224 c,一种预测的蛋白酶,作为巨噬细胞和体内存活的关键。我们推测Rv 2224 c是一个重要的毒力因子,它通过蛋白水解切割M。结核病基质和调节宿主免疫应答。我们的初步研究表明,Rv 2224 c输出到分枝杆菌的细胞被膜和分泌到细胞外。蛋白酶中被破坏的突变体在巨噬细胞和体内的生长受到损害。用蛋白酶突变体感染的小鼠显示出显著减少的肺病理学,并且比野生型感染的小鼠存活更长时间。在这个提议中,将研究蛋白酶在宿主-病原体相互作用中的作用。具体目标是:1. Rv 2224 c及其潜在底物在M.结核我们将研究Rv 2224 c在分枝杆菌中的定位,并对Rv 2224 c进行结构-功能分析。我们将通过研究候选生理底物来研究蛋白酶的生物活性和特异性。2.在巨噬细胞和体内研究蛋白酶与宿主免疫应答的相互作用。我们将研究对Rv 2224 c突变体的免疫应答的性质,特别是确定T和B细胞在免疫中的作用,并在巨噬细胞和体内进行蛋白酶与宿主相互作用的结构-功能分析。3.剖析蛋白酶对巨噬细胞功能的调节。我们将询问感染突变体是否会改变巨噬细胞的反应,并测试Rv 2224 c::tn突变体是否对IFN γ介导的免疫反应超敏感。最后,我们将研究Rv 2224是否直接与宿主细胞组分相互作用,
互动研究
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jyothi Rengarajan其他文献
Jyothi Rengarajan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jyothi Rengarajan', 18)}}的其他基金
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB
结核病保护性免疫和疫苗诱导免疫中的先天适应性串扰
- 批准号:
9412338 - 财政年份:2017
- 资助金额:
$ 1.04万 - 项目类别:
Targeting an immunomodulatory protease for adjunctive tuberculosis chemotherapy
靶向免疫调节蛋白酶用于结核病辅助化疗
- 批准号:
8996134 - 财政年份:2015
- 资助金额:
$ 1.04万 - 项目类别:
IMMUNE RESPONSES TO TUBERCULOSIS IN HIV POSITIVE AND HIV NEGATIVE INDIVIDUALS
HIV 阳性和 HIV 阴性个体对结核病的免疫反应
- 批准号:
8357494 - 财政年份:2011
- 资助金额:
$ 1.04万 - 项目类别:
MODULATION OF INNATE IMMUNE DEFENSES BY MYCOBACTERIUM TUBERCULOSIS
结核分枝杆菌对先天免疫防御的调节
- 批准号:
8357560 - 财政年份:2011
- 资助金额:
$ 1.04万 - 项目类别:
ROLE OF MYCOBACTERIUM TUBERCULOSIS PROTEASE IN PATHOGENESIS AND HOST RESPONSE
结核分枝杆菌蛋白酶在发病机制和宿主反应中的作用
- 批准号:
8357499 - 财政年份:2011
- 资助金额:
$ 1.04万 - 项目类别:
CELLULAR IMMUNE RESPONSES TO ACELLULAR PERTUSSIS VACCINATION IN INFANTS
婴儿无细胞百日咳疫苗接种的细胞免疫反应
- 批准号:
8357559 - 财政年份:2011
- 资助金额:
$ 1.04万 - 项目类别:
Modulation of Host Responses by Mycobacterium Tuberculosis
结核分枝杆菌对宿主反应的调节
- 批准号:
8259815 - 财政年份:2010
- 资助金额:
$ 1.04万 - 项目类别:
Modulation of Host Responses by Mycobacterium Tuberculosis
结核分枝杆菌对宿主反应的调节
- 批准号:
8464378 - 财政年份:2010
- 资助金额:
$ 1.04万 - 项目类别:
Modulation of Host Responses by Mycobacterium Tuberculosis
结核分枝杆菌对宿主反应的调节
- 批准号:
8065992 - 财政年份:2010
- 资助金额:
$ 1.04万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 1.04万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 1.04万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 1.04万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 1.04万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 1.04万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 1.04万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 1.04万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 1.04万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 1.04万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 1.04万 - 项目类别: